Biora Therapeutics Inc
NASDAQ:BIOR
Income Statement
Earnings Waterfall
Biora Therapeutics Inc
Income Statement
Biora Therapeutics Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
0
N/A
|
0
+233%
|
0
+70%
|
1
+135%
|
1
+15%
|
1
+30%
|
1
-1%
|
1
-30%
|
1
-12%
|
0
-59%
|
0
-37%
|
0
-53%
|
0
-89%
|
0
-60%
|
1
+13 450%
|
1
+59%
|
1
+4%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
+233%
|
0
+70%
|
1
+135%
|
1
+15%
|
1
+30%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(85)
|
(108)
|
(126)
|
(132)
|
(132)
|
(119)
|
(107)
|
(86)
|
(69)
|
(62)
|
(58)
|
(58)
|
(68)
|
(67)
|
(68)
|
(69)
|
(62)
|
|
| Selling, General & Administrative |
(45)
|
(60)
|
(67)
|
(75)
|
(76)
|
(73)
|
(67)
|
(53)
|
(42)
|
(38)
|
(33)
|
(33)
|
(38)
|
(37)
|
(38)
|
(37)
|
(35)
|
|
| Research & Development |
(37)
|
(48)
|
(48)
|
(49)
|
(49)
|
(46)
|
(41)
|
(33)
|
(27)
|
(24)
|
(25)
|
(25)
|
(29)
|
(30)
|
(30)
|
(31)
|
(26)
|
|
| Other Operating Expenses |
(4)
|
0
|
(11)
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(85)
N/A
|
(108)
-26%
|
(126)
-17%
|
(131)
-4%
|
(131)
+0%
|
(118)
+10%
|
(106)
+10%
|
(85)
+20%
|
(68)
+20%
|
(62)
+9%
|
(57)
+7%
|
(58)
-1%
|
(68)
-16%
|
(67)
+1%
|
(67)
+0%
|
(68)
-1%
|
(61)
+10%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(7)
|
(10)
|
(9)
|
(15)
|
(19)
|
(67)
|
(60)
|
(44)
|
(38)
|
16
|
8
|
(3)
|
0
|
1
|
20
|
35
|
39
|
|
| Non-Reccuring Items |
0
|
(11)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(6)
|
(2)
|
(2)
|
(3)
|
|
| Total Other Income |
(0)
|
(14)
|
1
|
4
|
5
|
7
|
(10)
|
(13)
|
(13)
|
(2)
|
(2)
|
(2)
|
(54)
|
(52)
|
(62)
|
(52)
|
(11)
|
|
| Pre-Tax Income |
(93)
N/A
|
(143)
-54%
|
(133)
+7%
|
(142)
-7%
|
(146)
-3%
|
(179)
-23%
|
(176)
+2%
|
(141)
+20%
|
(119)
+16%
|
(49)
+59%
|
(52)
-6%
|
(63)
-21%
|
(122)
-93%
|
(124)
-2%
|
(111)
+11%
|
(87)
+22%
|
(36)
+59%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
38
|
38
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(55)
|
(105)
|
(133)
|
(142)
|
(146)
|
(179)
|
(176)
|
(140)
|
(118)
|
(49)
|
(52)
|
(64)
|
(122)
|
(124)
|
(111)
|
(87)
|
(36)
|
|
| Net Income (Common) |
(117)
N/A
|
(193)
-64%
|
(208)
-8%
|
(233)
-12%
|
(230)
+1%
|
(247)
-8%
|
(229)
+7%
|
(156)
+32%
|
(117)
+25%
|
(38)
+67%
|
(42)
-9%
|
(54)
-29%
|
(122)
-126%
|
(124)
-1%
|
(111)
+11%
|
(87)
+22%
|
(32)
+64%
|
|
| EPS (Diluted) |
-62.71
N/A
|
-175.27
-179%
|
-83.49
+52%
|
-91.16
-9%
|
-60.06
+34%
|
-65.1
-8%
|
-31.23
+52%
|
-21.15
+32%
|
-15.68
+26%
|
-5.02
+68%
|
-3.8
+24%
|
-4.45
-17%
|
-8.15
-83%
|
-78.68
-865%
|
-37.84
+52%
|
-11.66
+69%
|
-8.63
+26%
|
|